Astrazeneca Phar (ASTRAZEN)

FAST GROWER

FairStock Score: 51/100 — MIXED

Score breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹8,449.4
Market Cap₹22,122.5 Cr
P/E Ratio106.34
ROCE33.4%
ROE26.08%
Dividend Yield0.36%
Profit Growth107.17%
Debt/Equity0.05
Sales Growth34.49%
Free Cash Flow₹9,616 Cr
Promoter Holding75%
52-Week Range₹7,551.5 — ₹10,691
SectorPharmaceuticals & Biotechnology
Book Value₹308.14

Astrazeneca Phar trades with a P/E ratio of 106.34, ROCE of 33.4%, ROE of 26.08%, profit growth of 107.17%, debt-to-equity of 0.05. The FairStock Score of 51/100 suggests mixed fundamentals — some metrics look solid while others need improvement.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer